POM
What one share of POMDOCTOR holds
Retail – Miscellaneous Retail
We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan.
POMDOCTOR’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.96 |
|---|---|
| Profit | −$0.51 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.36 |
| Cash and investments | $0.02 |
| Debt | $0.33 |
| Book value | −$1.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $1.14 | −$0.54 | $0.00 | −$0.17 | — | −$7.89 |
| 2024 | $1.26 | −$0.53 | $0.00 | −$0.06 | — | −$8.19 |
| 2025 | $0.96 | −$0.51 | $0.00 | −$0.36 | — | −$1.12 |